Narrow search
Showing 1 - 10 of 27,247
Cover Image
Umbrella branding in pharmaceutical markets
Suppliet, Moritz - 2017
Persistent link: https://www.econbiz.de/10011734578
Cover Image
Market power and regulation in pharmaceutical markets
Gugler, Klaus; Szücs, Florian - 2023
Persistent link: https://www.econbiz.de/10014321635
Cover Image
Bulk drug industry in India : challenges and prospects
James, T. C. - 2020
Persistent link: https://www.econbiz.de/10013466790
Cover Image
Parallel imports under a manufacturer rebate and a price freeze : evidence from Germany
Birg, Laura - In: Health economics 32 (2023) 2, pp. 302-323
Persistent link: https://www.econbiz.de/10014266802
Cover Image
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan; Mahlich, Jörg C. - In: Health economics review 4 (2014) 23, pp. 1-9
expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically … assessing the impact of regulation on pharmaceutical R&D expenditures. Methods: We analyze a sample of 20 leading pharmaceutical … companies between 2000 and 2008. The share of sales in Europe serves as a proxy for the degree of pharmaceutical regulation. We …
Persistent link: https://www.econbiz.de/10010526909
Cover Image
Is medicines parallel trade "regulatory arbitrage"?
Costa-Font, Joan - 2015
regulation, and not by price differences in line with the hypothesis of "regulatory arbitrage". …
Persistent link: https://www.econbiz.de/10010477153
Cover Image
Is self-regulation sufficient? : case of the German transparency code
Buske, Kristin; Jentzsch, Stefan J.; Bechter, Clemens - In: Administrative Sciences : open access journal 6 (2016) 1/3, pp. 1-12
The German pharmaceutical industry is stepping ahead with its implementation of a new transparency disclosure code for cooperation between pharmaceutical companies and health care professionals (HCPs) and health care organisations (HCOs). In Germany, this transparency code ("Transparenzkodex")...
Persistent link: https://www.econbiz.de/10012015756
Cover Image
Pharmaceutical regulation at the wholesale level and parallel trade
Birg, Laura - 2013
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by …
Persistent link: https://www.econbiz.de/10010223101
Cover Image
Regulation of pharmaceutical prices : evidence from a reference price reform in Denmark ; conference paper
Kaiser, Ulrich; Méndez, Susan; Rønde, Thomas; … - 2013 - This version: February 23, 2013
Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an "external" (based on a basket of prices in other countries) to an "internal" (based on comparable domestic products) reference price system. We find...
Persistent link: https://www.econbiz.de/10010339324